Skip to main content Skip to page footer

Cardiovascular aging

The heart ages

Particularly in view of the fact that the global population of people over 60 is expected to almost double to more than 2 billion by 2050 (World Health Organization), it is essential to ensure healthy aging as well as therapeutic measures for age-related diseases. All countries worldwide are increasingly faced with the challenge of preparing their health and social systems for this demographic shift and its associated consequences. In this context, the aging process represents a significant risk factor for the development of a wide range of diseases. In particular, aging is accompanied by profound changes in the cardiovascular system: at the cellular level, changes in mitochondria, the energy power plants of the cell, accumulation of free oxygen radicals, and increasing inflammatory processes accompanied by a limited repair capacity of the cells become apparent during the course of life. At the organ level, hypertrophy of the heart tissue and increased accumulation of connective tissue both in the heart (so-called myocardial fibrosis) and in the large vessels can be found, as well as the development of arteriosclerotic plaques and deterioration of cardiac function. These mechanisms, in complex interactions also with other organs, lead to the clinically visible pictures of hypertension, coronary heart disease, myocardial infarction and heart failure. Therefore, a significant increase in cardiovascular diseases can be expected, especially from the fifth decade of life. Research into and elucidation of these mechanisms and underlying causes, as well as their treatment and prevention, are essential to adequately counter the predicted massive increase in cardiovascular diseases, especially in the elderly population.

 

In biomedical research, various animal models are available to address research questions in cardiology. In particular, rodent species and pigs are currently used to study molecular and functional mechanisms of cardiac pathologies, to test new surgical methods and therapeutic options, or to identify potential biomarkers for cardiovascular diseases. Although a lot of essential information can be obtained in these animals, various inte-specific differences and their genetic distances to humans in some systems limit the translation of obtained knowledge to humans.

Here, the use of non-human primate species opens up new possibilities: particularly short-lived species such as the common marmoset (Callithrix jacchus, 300-500g, average age 12 years). These New-World primates show the first natural signs of aging such as cartilage defects, hearing loss and nerve cell degeneration already at the age of a few years. In addition, it is known from colony studies that they can develop obesity and diabetes, which makes them comparable to humans.

As part of the research focus "Cardiovascular Aging", our department is investigating and characterizing the common marmoset as a potential animal model for age-associated cardiovascular changes. Molecular biological investigations are used in an interdisciplinary project funded by the German Center for Cardiovascular Research e.V. (Deutsches Zentrum für Herz-Kreislauf-Forschung e.V.) together with functional cardiac catheterizations and non-invasive imaging techniques to collect physiological data for the species common marmoset. In cooperation with internal and external colleagues, additional organs will also be examined for signs of aging. In a second step, biomarkers and possible human-relevant therapeutic targets for the occurring changes will be identified before these can be tested in the future using disease models.

 

„Every person -in every country in the world- should have the opportunity to live a long and healthy life. “

World Health Organization (WHO)